Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables: 2024-2025

Historic Receivables for Gossamer Bio (GOSS) over the last 2 years, with Sep 2025 value amounting to $9.6 million.

  • Gossamer Bio's Receivables rose 44.18% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Gossamer Bio's Receivables stood at $9.6 million, which was up 20.85% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Receivables registered a high of $9.6 million during Q3 2025, and its lowest value of $3.9 million during Q2 2024.
  • For the 2-year period, Gossamer Bio's Receivables averaged around $6.7 million, with its median value being $6.7 million (2024).
  • Data for Gossamer Bio's Receivables shows a peak YoY surged of 103.08% (in 2025) over the last 5 years.
  • Over the past 2 years, Gossamer Bio's Receivables (Quarterly) stood at $5.5 million in 2024, then soared by 44.18% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $8.0 million for Q2 2025, and $6.7 million during Q1 2025.